Price$57.91-0.02 (-0.04%)
01:30 PM07:45 PM
News · 26 weeks36-54%
2026-04-192026-10-11
Mix2190d
- Analyst6(29%)
- Other5(24%)
- Insider4(19%)
- Earnings3(14%)
- SEC Filings2(10%)
- Leadership1(5%)
Latest news
25 items- ANALYSTBarclays initiated coverage on Cooper with a new price targetBarclays initiated coverage of Cooper with a rating of Equal Weight and set a new price target of $60.00
- PRNew CooperVision® Consumer Insights Report Reveals Multifocal Contact Lenses Are Viewed as a Leading Anti-Aging SolutionU.S. consumers ranked multifocal contact lenses among their preferred anti-aging solutions, highlighting untapped opportunities for earlier presbyopia conversations, and practice growthROCHESTER, N.Y., Oct. 1, 2026 /PRNewswire/ -- New research from CooperVision reveals that vision remains an overlooked, yet high potential part of the healthy aging conversation as consumers increasingly invest in products and services that help them look and feel younger. The Unmet Opportunities: Multifocal Contact Lenses and the Anti-Aging Movement (U.S.) report highlights evolving attitudes towards aging and receptiveness to multifocal contact lenses, revealing largely untapped opportunities for eye care pr
- PRSeneca Polytechnic and CooperVision Canada open Contact Lens Centre of Excellence to help advance the future of vision careTORONTO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- As the demand for vision care continues to grow, preparing the next generation of eye care professionals has never been more important. To help meet that need, Seneca Polytechnic and CooperVision Canada today announced the opening of the CooperVision Contact Lens Centre of Excellence, a state-of-the-art learning facility that will provide Opticianry students with enhanced hands-on training and real-world industry experience. Located at Seneca's Newnham Campus, the new Centre of Excellence reflects a shared commitment to advancing vision care through education, technological innovations and professional development. Equipped with industry-leading
- PRCOOPER COMPANIES, INC. COO INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 14.7% Share DropThe law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Cooper Companies, Inc. ("CooperCompanies" or the "Company") (NASDAQ:COO) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE FIRM’S INVESTIGATION]What Happened?On September 9, 2026, CooperCompanies announced its third quarter 2026 financial results, revealing quarterly revenue of approximately $1.07 billion, approximately $30 million short of the $1.10 billion analysts expected. The Company attributed these results to the performance of its CooperVision segment, which repor
- PRCooperCompanies Unveils Accelerated CooperVision Innovation Strategy at The Vision Centre OpeningSAN RAMON, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO) today reinforced its commitment to accelerate growth at CooperVision with the opening of its new global innovation hub, The Vision Centre, and the announcement of six major product advancements that have been accelerated to launch over the next several years: The build-out of the world's first & only complete family of 1-day contact lenses for myopia control, built on the world's #1 toric design;A novel premium 1-day silicone hydrogel (SiHy) technology;A next-generation SiHy material in a high-performing monthly contact lens;A differentiated entry 1-day SiHy innovation to drive new fits;The most advanced 1-
- PRCooperVision Powers the Next Era of Eye Care with New Global Vision Centre and Major Pipeline AdvancementsThe Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye CareROCHESTER, N.Y., Sept. 23, 2026 /CNW/ -- CooperVision today unveiled the grand opening of The Vision Centre, the company's new global innovation hub in Southampton, England, and announced six major product advancements that have been accelerated to launch over the next several years. The announcements were made as CooperVision brings together research and development, clinical expertise, pilot manufacturing, advanced technologies, and commercial capabilities to accelerate the development and commercialization of breakthrough solutions for patients and eye care professionals worldwide.
- PRJANA Partners Sends Letter to Cooper Board of DirectorsCalls for Board to Commence Immediate External CEO Search, Appoint New Board Chair and ExploreAsset SalesNEW YORK, Sept. 18, 2026 /PRNewswire/ -- JANA Partners ("JANA") today announced that it has sent a letter to the Board of Directors (the "Board") of The Cooper Companies, Inc. (NASDAQ:COO) ("Cooper" or the "Company") highlighting the companies consistent underperformance and calling on it to take several actions to improve shareholder value including the immediate initiation of an external search for a CEO, the appointment of a new board chair and the evaluation of asset sales. The full text of the letter is as follows:September 17, 2026Board of DirectorsThe Cooper Companies, Inc. ("Coope
- INSIDERDirector Kurzius Lawrence Erik bought $549,320 worth of shares (10,000 units at $54.93), increasing direct ownership by 47% to 31,099 units (SEC Form 4)4 - COOPER COMPANIES, INC. (0000711404) (Issuer)
- INSIDERDirector Rosebrough Walter M Jr bought $541,640 worth of shares (10,000 units at $54.16) (SEC Form 4)4 - COOPER COMPANIES, INC. (0000711404) (Issuer)
- INSIDERDirector Kurzius Lawrence Erik bought $539,150 worth of shares (10,000 units at $53.91), increasing direct ownership by 90% to 21,099 units (SEC Form 4)4 - COOPER COMPANIES, INC. (0000711404) (Issuer)
- INSIDERDirector Keel Paul A bought $250,000 worth of shares (4,701 units at $53.18) (SEC Form 4)4 - COOPER COMPANIES, INC. (0000711404) (Issuer)
- ANALYSTCooper downgraded by William BlairWilliam Blair downgraded Cooper from Outperform to Mkt Perform
- ANALYSTCooper downgraded by Piper Sandler with a new price targetPiper Sandler downgraded Cooper from Overweight to Neutral and set a new price target of $59.00
- ANALYSTCooper downgraded by Robert W. Baird with a new price targetRobert W. Baird downgraded Cooper from Outperform to Neutral and set a new price target of $61.00
- ANALYSTCooper downgraded by BofA Securities with a new price targetBofA Securities downgraded Cooper from Buy to Neutral and set a new price target of $65.00
- SECSEC Form 10-Q filed by The Cooper Companies Inc.10-Q - COOPER COMPANIES, INC. (0000711404) (Filer)
- SECSEC Form 8-K filed by The Cooper Companies Inc.8-K - COOPER COMPANIES, INC. (0000711404) (Filer)
- PRCooperCompanies Announces Third Quarter 2026 ResultsSAN RAMON, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2026. Revenue increased 1% year-over-year to $1.066 billion, including 1% organic growth.GAAP diluted earnings per share (EPS) of $2.24, compared with $0.49 in last year's third quarter, primarily driven by a $307.2 million discrete tax benefit resulting from the favorable completion of a U.K. tax examination.Non-GAAP diluted EPS of $1.15, up 4% from last year's third quarter. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below.Free cash flow increased 66% to $273.0 mil
- PRCooperCompanies Completes Strategic Review, Increases Share Repurchase AuthorizationBoard Unanimously Concludes to Retain CooperSurgical Expands Share Repurchase Authorization from $2 billion to $3 billion Board Remains Open to All Value Options that Create Shareholder Value SAN RAMON, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- CooperCompanies today announced the completion of its strategic review process first announced in December 2025. The comprehensive process focused on identifying opportunities to enhance long-term shareholder value including a review of the Company's portfolio, capital allocation priorities, strategic alternatives, corporate structure, leadership, operations, and strategy. As part of the process, the Board evaluated the sale of CooperSurgical.
- PRCooperCompanies Announces Release Date for Third Quarter 2026SAN RAMON, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, announced today it will report third quarter 2026 financial results on Wednesday, September 9, 2026, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 9708839. A simultaneous audio webcast and subsequent replay can be accessed at www.investor.coopercos.com About CooperCompanies CooperCompanies (NASDAQ:COO) is a leading global medical device company focused on helping people experience life’s be
- ANALYSTUBS initiated coverage on Cooper with a new price targetUBS initiated coverage of Cooper with a rating of Neutral and set a new price target of $75.00
- INSIDERSEC Form 4 filed by Director Keel Paul A4 - COOPER COMPANIES, INC. (0000711404) (Issuer)
- INSIDERSEC Form 3 filed by new insider Keel Paul A3 - COOPER COMPANIES, INC. (0000711404) (Issuer)
- PRCooperSurgical Supports Saving Mothers to Help Advance Global Women’s Health and Raise AwarenessCooperSurgical, a global leader in women’s health and fertility, today announced its support for Saving Mothers, a nonprofit organization dedicated to reducing maternal morbidity and mortality worldwide through innovative, scalable solutions. Founded by Taraneh Shirazian, MD, (@drshirazian) Saving Mothers focuses on improving maternal health outcomes by addressing critical gaps in care, education, and access to life-saving interventions. Dr. Shirazian is a practicing gynecologic surgeon, associate professor at NYU Langone Medical Center, and director of the Center for Fibroid care. "Saving Mothers commits to ensuring women everywhere have access to the care they need to survive and thri
- PRCooperCompanies Releases 2025 Corporate Sustainability Report with Scope 3 Emissions DisclosureSAN RAMON, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, released today its 2025 Corporate Sustainability Report. The report showcases the company’s commitment to people and planet, supported by expanded performance metrics and continued progress on sustainability priorities. A key milestone in this year’s report is the company’s first-time disclosure of Scope 3 greenhouse gas emissions, enhancing transparency and strengthening its sustainability reporting. "These achievements are the direct result of our global team’s partnership, innovation, and dedication to the customers and patients we serve," said Al White, CooperCom
COO FAQ
6 questionsWhat does The Cooper Companies Inc. do?
The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through two segments, CooperVision and CooperSurgical. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services for enhancing health of women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for...Where does COO stock trade?
The Cooper Companies Inc. (COO) is listed on NYSE.What sector and industry is COO in?
The Cooper Companies Inc. operates in the Health Care sector, Ophthalmic Goods industry.What are analysts saying about COO?
The Cooper Companies Inc. has had 8 recent analyst actions on file. The most recent action was from Barclays: Equal Weight on 2026-10-07.What companies are similar to COO?
Notable peers in the same industry include ALC (Alcon Inc.), BLCO (Bausch + Lomb Corporation), WRBY (Warby Parker Inc.), EYE (National Vision Holdings Inc.), STAA (STAAR Surgical Company). Compare COO side-by-side with any of them on Quantisnow.How can I track COO on Quantisnow?
Quantisnow aggregates The Cooper Companies Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow COO to receive live email and push alerts on every new disclosure.